MARKET

TIL

TIL

Instil Bio, Inc.
NASDAQ
8.07
-0.07
-0.86%
After Hours: 8.07 0 0.00% 16:10 06/05 EDT
OPEN
8.14
PREV CLOSE
8.14
HIGH
8.14
LOW
8.01
VOLUME
6.31K
TURNOVER
--
52 WEEK HIGH
42.79
52 WEEK LOW
5.67
MARKET CAP
54.73M
P/E (TTM)
-1.1397
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 2d ago
Weekly Report: what happened at TIL last week (0525-0529)?
Weekly Report · 5d ago
Allogene names Zachary Roberts CEO, succeeding David Chang effective July 1, 2026
PUBT · 05/28 21:02
Weekly Report: what happened at TIL last week (0518-0522)?
Weekly Report · 05/25 10:09
Weekly Report: what happened at TIL last week (0511-0515)?
Weekly Report · 05/18 10:09
Instil Bio Non-GAAP EPS of -$0.32
Seeking Alpha · 05/15 11:12
Earnings Scheduled For May 15, 2026
Benzinga · 05/15 11:11
Instil Bio Q1 net loss narrows on lower R&D expenses
Reuters · 05/15 11:07
More
About TIL
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. The Company’s subsidiary, Axion Bio, Inc., in-licensed certain bispecific antibodies, including AXN-2510/IMM2510 and AXN-27M/IMM27M, a monoclonal antibody targeting cytotoxic T-lymphocyte associated antigen 4, or CTLA-4. AXN-2510/IMM2510, the lead in-licensed product candidate, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid tumor cancers. AXN-27M/IMM27M is an antibody-dependent cellular cytotoxicity-enhanced monoclonal antibody targeting CTLA-4, which has been designed to promote intratumoral regulatory T cell depletion to enhance the efficacy and reduce the toxicity associated with first-generation anti-CTLA-4 antibodies.

Webull offers Instil Bio Inc stock information, including NASDAQ: TIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TIL stock methods without spending real money on the virtual paper trading platform.